Otenzepad ≥98%
促销价¥{{model.attbuying.price}}
市场价¥0.00
累计销量0 累计评价0 人评论
-
{{item.title}}
| 包装规格: | 5mg 10mg 25mg 50mg 100mg in glass bottle |
| 溶解性: | 溶于DMSO(5mg/mL 加热) |
| 产品描述: | 基本信息 产品编号: O70019 产品名称: Otenzepad CAS: 102394-31-0 储存条件 粉末 -20℃ 四年 分子式: C24H31N5O2 溶于液体 -80℃ 6个月 分子量: 421.54 -20℃ 1个月 化学名: 11-(2-(2-((Diethylamino)methyl)piperidin-1-yl)acetyl)-5H-benzo[e]pyrido[3,2-b][1,4]diazepin-6(11H)-one Solubility (25°C): 体外: DMSO Ethanol Water 体内(现配现用): <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 生物活性 产品描述 一种选择性的、竞争性的 M2 毒蕈碱乙酰胆碱受体拮抗剂,对兔外周肺和大鼠心脏的 IC50 值分别为 640nM 和 386nM。 靶点 640nM (M2 muscarinic acetylcholine receptor in rabbit peripheral lung),386nM (M2 muscarinic acetylcholine receptor in rat heart). 体内研究 Otenzepad (0.5,1mg/kg,s.c.,in rats) significantly improved win-stay acquisition relative to vehicle-injected controls.Otenzepad (2mg/kg,s.c.,in rats) significantly improved retention relative to vehicle controls.Otenzepad (0.3,1.0,or 3.0mg/kg,ip,in mice) potentiates the effects of glucose and reverses the effects of insulin on memory. Animal Model: Forty-eight male Long-Evans rats (325-350g). Dosage: 0.25,0.5,1.0 and 2.0mg/kg. Administration: S.C.on the dorsum of the neck once. Result: Doses of 0.5 and 1.0mg/kg significantly improved acquisition relative to vehicle controls,while doses of 0.25 and 2.0mg/kg had no effect. Animal Model: Adult male Swiss mice (age 60–70 days;weight 25-30g). Dosage: 0.3,1.0,or 3.0mg/kg. Administration: IP once. Result: Enhanced retention in an inverted-U dose–response manner,with significant enhancement seen at 1.0mg/kg (U15,15=49,p<0.02,compared with saline-salineinjected control group). |
| 保存条件: | -20℃ |
-
蜀牛玻璃三角瓶
¥85.00 销量:16
-
15mL锥底离心管,袋装灭菌,橙色盖
¥636.00 销量:12
-
UFC5030BK 超滤管[0.5ml 30KD]
¥52.00 销量:10
-
UFC5010BK 超滤管[0.5ml 10KD]
¥52.00 销量:10
-
20×TBST缓冲液
¥130.00 销量:10
-
10mL移液管,易撕型全塑包装
¥456.00 销量:10
-
¥158.00
通用型 DNA 纯化回收试剂盒 -
¥158.00
质粒快速小提试剂盒 -
¥828.00
100mm TC细胞培养皿,袋装灭菌

